Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0625|27|1|64-70

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.27, Iss.1, 2018-01, pp. : 64-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

M1 and M2 Macrophages: The Chicken and the Egg of Immunity

By  

Journal of Innate Immunity, Vol. 6, Iss. 6, 2014-08 ,pp. : 716-726

Karger

Access to resources Recommend Favorite

Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 8, 2015-08 ,pp. : 576-578

John Wiley & Sons Inc

Access to resources Recommend Favorite

M2 macrophages coexist with a Th1‐driven profile in periapical cysts

By  

INTERNATIONAL ENDODONTIC JOURNAL, Vol. 51, Iss. S2, 2018-02 ,pp. : e87-e93

John Wiley & Sons Inc

Access to resources Recommend Favorite

CSF-1 (M-CSF) Enhances the Inflammatory Response of Fibronectin-Primed Macrophages: Pathways Involved in Activation of the Cytokine Network

By  

Natural Immunity, Vol. 16, Iss. 5-6, 2000-09 ,pp. : 228-243

Karger

Access to resources Recommend Favorite

Induction of M2 Regulatory Macrophages through the β2-Adrenergic Receptor with Protection during Endotoxemia and Acute Lung Injury

By  

Journal of Innate Immunity, Vol. 6, Iss. 5, 2014-03 ,pp. : 607-618

Karger

Access to resources Recommend Favorite